Spotlight on AbbVie: Analyzing the Surge in Options Activity
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Deep-pocketed investors have adopted a bullish approach towards AbbVie (NYSE:ABBV), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ABBV usually suggests something big is about to happen.
财力雄厚的投资者对艾伯维（纽约证券交易所代码：ABBV）采取了看涨态度，这是市场参与者不容忽视的。我们对本辛加公开期权记录的追踪今天揭示了这一重大举措。这些投资者的身份仍然未知，但是ABBV的如此重大变动通常表明即将发生重大事件。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for AbbVie. This level of activity is out of the ordinary.
我们今天从观察中收集了这些信息，当时Benzinga的期权扫描仪重点介绍了AbbVie的8项非同寻常的期权活动。这种活动水平与众不同。
The general mood among these heavyweight investors is divided, with 62% leaning bullish and 25% bearish. Among these notable options, 3 are puts, totaling $513,300, and 5 are calls, amounting to $229,374.
这些重量级投资者的总体情绪存在分歧，62％的人倾向于看涨，25％的人倾向于看跌。在这些值得注意的期权中，有3个是看跌期权，总额为513,300美元，5个是看涨期权，总额为229,374美元。
Expected Price Movements
预期的价格走势
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $210.0 for AbbVie over the recent three months.
根据交易活动，看来重要投资者的目标是在最近三个月中将AbbVie的价格范围从150.0美元扩大到210.0美元。
Analyzing Volume & Open Interest
分析交易量和未平仓合约
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
查看交易量和未平仓合约是一种对股票进行尽职调查的有见地的方法。
This data can help you track the liquidity and interest for AbbVie's options for a given strike price.
这些数据可以帮助您跟踪给定行使价下艾伯维期权的流动性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale activity within a strike price range from $150.0 to $210.0 in the last 30 days.
下面，我们可以分别观察过去30天在150.0美元至210.0美元行使价范围内艾伯维所有鲸鱼活动的看涨和看跌期权交易量和未平仓合约的变化。
AbbVie Option Volume And Open Interest Over Last 30 Days
过去 30 天的 AbbVie 期权交易量和未平仓合约
Noteworthy Options Activity:
值得注意的期权活动：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | PUT | TRADE | NEUTRAL | 12/19/25 | $22.15 | $21.7 | $21.9 | $200.00 | $438.0K | 236 | 200 |
| ABBV | CALL | SWEEP | BEARISH | 11/15/24 | $2.75 | $2.74 | $2.75 | $210.00 | $52.0K | 1.6K | 199 |
| ABBV | CALL | TRADE | BULLISH | 01/17/25 | $18.15 | $17.9 | $18.1 | $185.00 | $50.6K | 3.7K | 31 |
| ABBV | CALL | TRADE | BULLISH | 09/20/24 | $16.9 | $16.55 | $16.9 | $180.00 | $47.3K | 4.3K | 40 |
| ABBV | PUT | TRADE | BULLISH | 01/16/26 | $6.45 | $6.2 | $6.2 | $150.00 | $46.5K | 338 | 77 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | 放 | 贸易 | 中立 | 12/19/25 | 22.15 美元 | 21.7 美元 | 21.9 美元 | 200.00 美元 | 438.0 万美元 | 236 | 200 |
| ABBV | 打电话 | 扫 | 粗鲁的 | 11/15/24 | 2.75 美元 | 2.74 美元 | 2.75 美元 | 210.00 美元 | 52.0 万美元 | 1.6K | 199 |
| ABBV | 打电话 | 贸易 | 看涨 | 01/17/25 | 18.15 美元 | 17.9 美元 | 18.1 美元 | 185.00 美元 | 50.6 万美元 | 3.7K | 31 |
| ABBV | 打电话 | 贸易 | 看涨 | 09/20/24 | 16.9 美元 | 16.55 美元 | 16.9 美元 | 180.00 美元 | 47.3 万美元 | 4.3K | 40 |
| ABBV | 放 | 贸易 | 看涨 | 01/16/26 | 6.45 美元 | 6.2 美元 | 6.2 美元 | 150.00 美元 | 46.5 万美元 | 338 | 77 |
About AbbVie
关于 AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
艾伯维是一家制药公司，在免疫学（与Humira、Skyrizi和Rinvoq合作）和肿瘤学（与Imbruvica和Venclexta合作）方面有着丰富的经验。该公司于2013年初从雅培分拆出来。2020年对Allergan的收购增加了几种美容领域的新产品和药物（包括肉毒杆菌毒素）。
After a thorough review of the options trading surrounding AbbVie, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在对围绕AbbVie的期权交易进行了全面审查之后，我们将对该公司进行更详细的审查。这包括评估其当前的市场状况和表现。
AbbVie's Current Market Status
艾伯维当前的市场状况
- With a volume of 3,466,441, the price of ABBV is up 1.56% at $196.42.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 46 days.
- ABBV的交易量为3,466,441美元，上涨1.56％，至196.42美元。
- RSI指标暗示标的股票可能接近超买。
- 下一份财报预计将在46天后公布。
Professional Analyst Ratings for AbbVie
AbbVie的专业分析师评级
2 market experts have recently issued ratings for this stock, with a consensus target price of $213.5.
2位市场专家最近发布了该股的评级，共识目标价为213.5美元。
- Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on AbbVie with a target price of $218.
- Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on AbbVie with a target price of $209.
- 摩根士丹利的一位分析师在评估中保持对AbbVie的增持评级，目标价为218美元。
- 派珀·桑德勒的一位分析师在评估中保持了对艾伯维的增持评级，目标价为209美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AbbVie options trades with real-time alerts from Benzinga Pro.
期权交易带来更高的风险和潜在的回报。精明的交易者通过不断自我教育、调整策略、监控多个指标以及密切关注市场走势来管理这些风险。通过Benzinga Pro的实时提醒，随时了解最新的AbbVie期权交易。